Development and Preclinical Evaluation of Radiolabeled Covalent G12C-Specific Inhibitors for Direct Imaging of the Oncogenic KRAS Mutant.
Mol Pharm
; 18(9): 3509-3518, 2021 09 06.
Article
in En
| MEDLINE
| ID: mdl-34410132
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Piperazines
/
Quinazolines
/
Proto-Oncogene Proteins p21(ras)
/
Radiopharmaceuticals
/
Protein Kinase Inhibitors
/
Neoplasms
Type of study:
Prognostic_studies
Limits:
Animals
/
Female
/
Humans
Language:
En
Journal:
Mol Pharm
Journal subject:
BIOLOGIA MOLECULAR
/
FARMACIA
/
FARMACOLOGIA
Year:
2021
Document type:
Article
Affiliation country:
China
Country of publication:
Estados Unidos